Neoadjuvant endocrine therapy - designed to reduce the size of breast tumors before surgical removal - appears to be as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast ...
Nov 9, 2016
0
4
Leukemia itself, not just side effects related to its treatment, may increase the risk for long-term problems with attention, organization and related neurocognitive skills in survivors of the most common childhood cancer, ...
Mar 29, 2018
1
34
The results of a large, retrospective study of patients who received a form of immunotherapy for non-small cell lung cancer (NSCLC) revealed that patients may get more than one immune-related side effect, and identified a ...
Dec 14, 2020
0
6
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.
Jan 18, 2018
0
13
The NRG Oncology and the American College of Radiology Network (ACRIN) multicenter, phase II trial, NRG-RTOG 1106/ACRIN 6697, is the first randomized trial to demonstrate the feasibility and safety of performing adaptive ...
Jan 29, 2021
0
5
The prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.
Jan 15, 2024
0
0
(HealthDay)—Radiation oncology (RO) and medical oncology (MO) academic faculty have increased the representation of women from 1970 through 2019, but inclusion of those underrepresented in medicine (URM) has lagged, according ...
Dec 21, 2021
0
3
A rare but aggressive kind of uterine cancer appears to be driving an increase in U.S. deaths from the disease, particularly among Black women, researchers reported Thursday.
May 5, 2022
0
30
(HealthDay)—The rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is 0.68 percent among patients receiving antitumor treatment, according to a research letter published online Dec. 17 in JAMA ...
Dec 28, 2020
0
8
While aromatase inhibitors (AIs) are a preferred therapy for postmenopausal women who have hormone receptor-positive early-stage breast cancer, the vaginal dryness and decreased sex drive that may result can lead to poor ...
Nov 10, 2016
0
0
